Literature DB >> 17981726

Nuclear phospholipase C beta1 and cellular differentiation.

Irene Faenza1, Lisa Bregoli, Giulia Ramazzotti, Giancarlo Gaboardi, Matilde Y Follo, Sara Mongiorgi, Anna Maria Billi, Lucia Manzoli, Alberto M Martelli, Lucio Cocco.   

Abstract

Phosphoinositides (PI) are the most extensively studied lipids involved in cell signaling pathways. The bulk of PI is found in membranes where they are substrates for enzymes, such as kinases, phosphatases and phospholipases, which respond to the activation by cell-surface receptors. The outcome of the majority of signaling pathways involving lipid second messengers results in nuclear responses finally driving the cell into differentiation, proliferation or apoptosis. Some of these pathways are well established, such as that of PI-specific phospholipase C (PI-PLC), which cleaves phosphatidylinositol-4,5-bisphosphate (PIP2) into the two second messengers diacylglycerol (DAG) and inositol-1,4,5-trisphosphate (IP3). Two independent cycles of PI are present inside the cell. One is localized at the plasma membrane, while the most recently discovered PI cycle is found inside the nuclear compartment. The regulation of the nuclear PI pool is totally independent from the plasma membrane counterpart, suggesting that the nucleus constitutes a functionally distinct compartment of inositol lipids metabolism. In this report we will focus on the signal transduction-related metabolism of nuclear PI and review the most convincing evidence that the PI cycle is involved in differentiation programs in several cell systems.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17981726     DOI: 10.2741/2858

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  6 in total

1.  The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels.

Authors:  Fabio A Iannotti; Cristoforo Silvestri; Enrico Mazzarella; Andrea Martella; Daniela Calvigioni; Fabiana Piscitelli; Paolo Ambrosino; Stefania Petrosino; Gabriella Czifra; Tamás Bíró; Tibor Harkany; Maurizio Taglialatela; Vincenzo Di Marzo
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-03       Impact factor: 11.205

2.  The effect of imiquimod on taste bud calcium transients and transmitter secretion.

Authors:  Anthony Y Huang; Sandy Y Wu
Journal:  Br J Pharmacol       Date:  2016-09-06       Impact factor: 8.739

3.  Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS.

Authors:  Matilde Y Follo; Carlo Finelli; Sara Mongiorgi; Cristina Clissa; Costanza Bosi; Nicoletta Testoni; Francesca Chiarini; Giulia Ramazzotti; Michele Baccarani; Alberto M Martelli; Lucia Manzoli; Giovanni Martinelli; Lucio Cocco
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-10       Impact factor: 11.205

Review 4.  Mutations in phosphoinositide metabolizing enzymes and human disease.

Authors:  Heather J McCrea; Pietro De Camilli
Journal:  Physiology (Bethesda)       Date:  2009-02

5.  Opposing calcium-dependent signalling pathways control skeletal muscle differentiation by regulating a chromatin remodelling enzyme.

Authors:  Brian T Nasipak; Teresita Padilla-Benavides; Karin M Green; John D Leszyk; Wenjie Mao; Silvana Konda; Saïd Sif; Scott A Shaffer; Yasuyuki Ohkawa; Anthony N Imbalzano
Journal:  Nat Commun       Date:  2015-06-17       Impact factor: 14.919

6.  Nuclear phosphoinositide-specific phospholipase C β1 controls cytoplasmic CCL2 mRNA levels in HIV-1 gp120-stimulated primary human macrophages.

Authors:  Francesca Spadaro; Serena Cecchetti; Cristina Purificato; Michela Sabbatucci; Franca Podo; Carlo Ramoni; Sandra Gessani; Laura Fantuzzi
Journal:  PLoS One       Date:  2013-03-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.